Literature DB >> 24814199

Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.

Peter J Smit1, Weidun A Guo2, Bruce A Davidson3, Barbara A Mullan3, Jadwiga D Helinski3, Paul R Knight3.   

Abstract

BACKGROUND: Gastric aspiration is a significant cause of acute lung injury and acute respiratory distress syndrome. Environmental risk factors, such as a diet high in proinflammatory advanced glycation end-products (AGEs), may render some patients more susceptible to lung injury after aspiration. We hypothesized that high dietary AGEs increase its pulmonary receptor, RAGE, producing an amplified pulmonary inflammatory response in the presence of high mobility group box 1 (HMGB1), a RAGE ligand and an endogenous signal of epithelial cell injury after aspiration.
MATERIALS AND METHODS: CD-1 mice were fed either a low AGE or high AGE diet for 4 wk. After aspiration injury with acidified small gastric particles, bronchoalveolar lavage and whole-lung tissue samples were collected at 5 min, 1 h, 5 h, and 24 h after injury. RAGE, soluble RAGE (sRAGE), HMGB1, cytokine and chemokine concentrations, albumin levels, neutrophil influx, and lung myeloperoxidase activity were measured.
RESULTS: We observed that high AGE-fed mice exhibited greater pulmonary RAGE levels before aspiration and increased bronchoalveolar lavage sRAGE levels after aspiration compared with low AGE-fed mice. Lavage HMGB1 levels rose immediately after aspiration, peaking at 1 h, and strongly correlated with sRAGE levels in both dietary groups. High AGE-fed mice demonstrated higher cytokine and chemokine levels with increased pulmonary myeloperoxidase activity over 24 h versus low AGE-fed mice.
CONCLUSIONS: This study indicates that high dietary AGEs can increase pulmonary RAGE, augmenting the inflammatory response to aspiration in the presence of endogenous damage signals such as HMGB1.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute lung injury; Advanced glycation end-products; Gastric aspiration; High mobility group box 1; Receptor for advanced glycation end-products

Mesh:

Substances:

Year:  2014        PMID: 24814199      PMCID: PMC4134762          DOI: 10.1016/j.jss.2014.04.001

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  48 in total

1.  Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study.

Authors:  Ognjen Gajic; Ousama Dabbagh; Pauline K Park; Adebola Adesanya; Steven Y Chang; Peter Hou; Harry Anderson; J Jason Hoth; Mark E Mikkelsen; Nina T Gentile; Michelle N Gong; Daniel Talmor; Ednan Bajwa; Timothy R Watkins; Emir Festic; Murat Yilmaz; Remzi Iscimen; David A Kaufman; Annette M Esper; Ruxana Sadikot; Ivor Douglas; Jonathan Sevransky; Michael Malinchoc
Journal:  Am J Respir Crit Care Med       Date:  2010-08-27       Impact factor: 21.405

Review 2.  Models and mechanisms of acute lung injury caused by direct insults.

Authors:  Lucy Kathleen Reiss; Ulrike Uhlig; Stefan Uhlig
Journal:  Eur J Cell Biol       Date:  2012-01-26       Impact factor: 4.492

3.  Acid aspiration-induced lung inflammation and injury are exacerbated in NADPH oxidase-deficient mice.

Authors:  Brahm H Segal; Bruce A Davidson; Alan D Hutson; Thomas A Russo; Bruce A Holm; Barbara Mullan; Michael Habitzruther; Steven M Holland; Paul R Knight
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-11-17       Impact factor: 5.464

4.  Contribution of high-mobility group box-1 to the development of ventilator-induced lung injury.

Authors:  Eileen N Ogawa; Akitoshi Ishizaka; Sadatomo Tasaka; Hidefumi Koh; Hiroshi Ueno; Fumimasa Amaya; Masahito Ebina; Shingo Yamada; Yosuke Funakoshi; Junko Soejima; Kiyoshi Moriyama; Toru Kotani; Satoru Hashimoto; Hiroshi Morisaki; Edward Abraham; Junzo Takeda
Journal:  Am J Respir Crit Care Med       Date:  2006-05-25       Impact factor: 21.405

5.  Acid and particulate-induced aspiration lung injury in mice: importance of MCP-1.

Authors:  Krishnan Raghavendran; Bruce A Davidson; Barbara A Mullan; Alan D Hutson; Thomas A Russo; Patricia A Manderscheid; James A Woytash; Bruce A Holm; Robert H Notter; Paul R Knight
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-03-18       Impact factor: 5.464

6.  RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages.

Authors:  R Kokkola; A Andersson; G Mullins; T Ostberg; C-J Treutiger; B Arnold; P Nawroth; U Andersson; R A Harris; H E Harris
Journal:  Scand J Immunol       Date:  2005-01       Impact factor: 3.487

7.  TNF-induced death signaling triggers alveolar epithelial dysfunction in acute lung injury.

Authors:  Brijesh V Patel; Michael R Wilson; Kieran P O'Dea; Masao Takata
Journal:  J Immunol       Date:  2013-03-13       Impact factor: 5.422

8.  HMGB1 is an endogenous immune adjuvant released by necrotic cells.

Authors:  Patrizia Rovere-Querini; Annalisa Capobianco; Paola Scaffidi; Barbara Valentinis; Federica Catalanotti; Marta Giazzon; Ingrid E Dumitriu; Susanne Müller; Matteo Iannacone; Catia Traversari; Marco E Bianchi; Angelo A Manfredi
Journal:  EMBO Rep       Date:  2004-07-23       Impact factor: 8.807

9.  Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects.

Authors:  K Nakamura; S I Yamagishi; T Matsui; H Adachi; M Takeuchi; T Imaizumi
Journal:  Clin Exp Med       Date:  2008-01-11       Impact factor: 3.984

Review 10.  The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?

Authors:  Benedict C Creagh-Brown; Gregory J Quinlan; Timothy W Evans; Anne Burke-Gaffney
Journal:  Intensive Care Med       Date:  2010-07-15       Impact factor: 17.440

View more
  3 in total

1.  Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.

Authors:  P Gopal; H R Gosker; C C de Theije; I M Eurlings; D R Sell; V M Monnier; N L Reynaert
Journal:  Biochim Biophys Acta       Date:  2015-02-19

2.  Xuebijing Ameliorates Sepsis-Induced Lung Injury by Downregulating HMGB1 and RAGE Expressions in Mice.

Authors:  Qiao Wang; Xin Wu; Xiaowen Tong; Zhiling Zhang; Bing Xu; Wugang Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-02       Impact factor: 2.629

Review 3.  Emerging role of HMGB1 in lung diseases: friend or foe.

Authors:  Junying Ding; Xuran Cui; Qingquan Liu
Journal:  J Cell Mol Med       Date:  2016-12-31       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.